Atlanticus Announces Approval of Quarterly Preferred Stock Dividend

(NASDAQ:ATLC), ATLANTA, Jan. 29, 2025 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we” or “our”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that its Board of Directors approved a quarterly dividend of $0.476563 […]

Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025

(Paris:NANO),(NASDAQ: NBTX), PARIS and CAMBRIDGE, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO — NASDAQ: NBTX – the ''Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conferences: Guggenheim

Presidio Property Trust Provides Update on Model Home Activity in Q4 2024

(NASDAQ:SQFT),(NASDAQ:SQFTP),(NASDAQ:SQFTW), SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) — (NASDAQ: SQFT; SQFTP; SQFTW) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust (“REIT”) announced that in the fourth quarter of 2024, through subsidiary and affiliate entities, have sold five homes for a total of approximately $2.7 million. These

HCI Group Sets Fourth Quarter and Full Year 2024 Earnings Call for Thursday, February 27, 2025, at 4:45 p.m. ET

(NYSE:HCI), TAMPA, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, will hold a conference call on Thursday, February 27, 2025, at 4:45 p.m. Eastern time to discuss results for the fourth quarter and year ended December

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

(NASDAQ:CERT), RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss

Matthews International Declares Quarterly Dividend

(NASDAQ:MATW), PITTSBURGH, Jan. 29, 2025 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) announced that its Board of Directors declared, at its regularly scheduled meeting today, a dividend of $0.25 per share on the Company's common stock. The dividend is payable February 24, 2025 to stockholders of record February 10, 2025. About Matthews International

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that Dr. Jacqueline Shea, INOVIO's President and CEO, and Dr. Michael Sumner, Chief Medical Officer, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg

Consumers Energy and Hecate Energy Break Ground on 360 MW Sunfish Solar 2 Renewable Energy Project

NewCalhoun County Clean Energy Facility to Advance Customer Priorities, Strengthen Electric Grid, and Offer Clean Energy Options for Regional Businesses Consumers Energy and Hecate Energy (“Hecate”) announced today that initial site work by Bechtel has begun on the 360-megawatt (MW) Sunfish Solar 2 project, progressing with a target completion date of Q2 2026. The project

Hawkins, Inc. Reports Third Quarter Fiscal 2025 Results

(NASDAQ:HWKN), ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization

PharmAla Issues Q1 Financial Statements

(CNSX:MDMA.CN),(CNSX:MDMA),(OTC US:MDXXF),(Other OTC:MDXXF), TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo(TM) MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for

Scroll to Top